J-Valve study for leaky aortic valve patients
Part of Heart & circulation clinical trials.
This study tests a new, less invasive device called J-Valve for people with severe aortic regurgitation (a leaky aortic valve). It is placed through a tube in the leg artery, avoiding open-heart surgery, and may help those who are at high risk for surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have severe aortic regurgitation (a leaky heart valve) and have symptoms like shortness of breath or fatigue.
- Your heart team has decided that standard surgery would be too risky for you.
- Your valve anatomy is suitable for the J-Valve device (doctors will check with imaging).
- You have not had a previous aortic valve replacement surgery.
- You do not have severe other heart valve problems, active infections, or advanced kidney/liver disease.
- Your heart function is not too weak (ejection fraction greater than 25%).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device to treat a leaking aortic valve in people who already have a left ventricular assist device (LVAD). The goal is to fix the leak without open-heart surgery, which may improve how well the LVAD works and reduce symptoms.
This trial tests a new, less invasive device called the AltaValve to treat a leaky mitral valve. It is for people whose leak is severe enough to cause symptoms, but who cannot have standard surgery or a clip procedure.
This trial compares a new catheter-based valve (J-Valve) with open-heart surgery for people with severe aortic regurgitation, a condition where the aortic valve doesn't close tightly. It aims to see which treatment is safer and more effective.
This study is for people with a severe leaking aortic valve (aortic regurgitation) who are too high-risk for open-heart surgery. It tracks how well a less-invasive valve replacement (TAVI) using the JenaValve or J-Valve works for them.
This trial studies a less invasive heart valve procedure that places a new valve through a catheter, to treat severe leakage of the aortic valve. It may help people who have symptoms or heart enlargement and who are at higher risk for open-heart surgery.
This study is testing a new valve device (JenaValve Trilogy) that can be placed without open-heart surgery. It may be an option for people whose heart team says regular valve replacement surgery is too risky.
Hear when a new Aortic Valve Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.